Is Anyone Watching Who Owns Your Ophthalmologist's Practice?

Ask a patient who owns their ophthalmologist's practice, and most can't answer the question, not because they have never thought about it, but because the structure is genuinely difficult to determine from the outside looking in. A practice can operate under a familiar local name, staffed by the same doctor a patient has seen for years and trusts completely, while the actual ownership and financial control sit several layers away in a management company, a holding entity, or a private equity fund the patient has never heard of and would have no easy or obvious way to discover on their own.

This isn't an accident of unavoidable complexity. In states with corporate practice of medicine restrictions, ownership structures are often built specifically to satisfy the letter of a law requiring physician ownership on paper while placing effective financial control somewhere else entirely, through management agreements, long-term contracts, and fee structures that direct most of a practice's actual economics to a non-physician-owned entity operating one layer removed. The physician's name is on the door and on the diploma on the wall. The physician isn't always the one making the decisions that matter most to how the practice runs.

Why Ophthalmology Ownership Structures Are So Hard to See

The opacity here isn't limited to patients alone. Many physicians joining a practice or a platform have limited visibility into who ultimately controls the entity they're signing an agreement with, particularly once that entity has been resold, restructured, or absorbed into a larger platform sometime after the physician's original agreement was already signed and filed away. A physician can join a locally-branded practice believing they understand its ownership clearly, only to learn much later that the actual controlling entity changed hands, sometimes more than once in succession, without the physician ever being part of that conversation or even notified promptly when it happened.

Regulators have started paying closer attention to this exact gap in recent years. The Federal Trade Commission's premerger notification framework, which determines which healthcare transactions require advance regulatory review before closing, has been the subject of active rule changes, including a February 2026 vacatur that reopened serious questions about how much visibility regulators actually have into the roll-up transactions reshaping physician practice ownership nationally at scale. The debate reflects a broader, still-unresolved question worth sitting with. If regulators themselves are still working out how to track who owns what across healthcare consolidation, patients and physicians navigating that same landscape without any regulatory tools of their own are operating with considerably less visibility still.

What Ophthalmology Ownership Transparency Would Require

Meaningful transparency here doesn't require an ownership structure to be simple, since some complexity in healthcare entities exists for legitimate legal and regulatory reasons that serve real purposes. It requires only that the structure be disclosable and understandable to the people most affected by it, specifically the physicians signing agreements and the patients receiving care under them. That's a materially lower bar than eliminating MSO structures or corporate practice of medicine frameworks, and it's a bar the current landscape frequently fails to clear regardless of how low it sits.

A physician considering a practice affiliation should be able to answer a small set of basic questions before ever signing anything binding. Who ultimately controls the entity holding the management agreement in question. What happens to that agreement if the controlling entity is sold to someone else down the line. Whether the physician has any consent rights over a future sale, or whether that decision sits outside their control regardless of how the practice performs under their leadership. These aren't exotic or unreasonable questions to ask upfront. They're the baseline information any physician should have clearly in hand before entering a long-term agreement, and the fact that many physicians currently don't have clear answers to them going in says considerably more about the industry's current norms than about any individual physician's diligence or carefulness.

Why This Matters Beyond Any Single Ophthalmology Transaction

The stakes here extend well beyond any individual deal or any single physician's personal situation. An industry where ownership structures are difficult to trace makes it harder for physicians to learn from each other's experiences over time, because 2 doctors describing what sounds like a similar arrangement to each other may actually be operating under very different ownership realities underneath a similar-looking surface agreement. It also makes it harder for patients to factor ownership into where they choose to seek care, even for the patients who would specifically prefer an independent, physician-controlled practice if only they were able to reliably identify one from the outside.

Transparency isn't a burden waiting to be imposed on the industry from some outside regulator with an agenda. It's a basic condition for physicians and patients alike to make informed decisions, the same condition that already exists as standard practice in most other consumer-facing industries where ownership disclosure is simply expected as a matter of course. Ophthalmology, and healthcare more broadly across nearly every specialty, has been a notable exception to that norm for a long time now, and closing that gap doesn't require waiting on new federal law before individual physicians and practices can simply start being straightforward about a question that should never have been difficult to answer honestly in the first place.

What Ophthalmology Physicians and Patients Should Be Asking Now

The near-term fix doesn't require waiting on federal rulemaking to work its way through Washington. Any physician evaluating a practice affiliation today can simply ask who controls it, what happens on a future sale down the road, and whether they personally have any say in that eventual outcome, and any practice genuinely confident in its own structure should have no real difficulty answering those questions plainly and without hesitation. The practices that struggle to answer clearly, that deflect or grow vague under a direct question like this, are usually the ones with the most reason to prefer that the question never gets asked at all, which is itself useful information for anyone currently deciding whether to sign.

The same standard applies just as reasonably to patients, even if the mechanism for asking is less direct than it's for a physician reviewing a contract. A patient curious about who ultimately owns their practice is well within reason to simply ask the front desk or the physician directly, and a practice with nothing to hide should be able to answer plainly without treating the question as an intrusion. An industry that normalizes that kind of straightforward answer, rather than treating ownership as a detail patients have no reason to know, will end up earning a kind of trust that opaque structures never fully manage to build, no matter how well they perform on every other measure that matters to a patient sitting in the waiting room. That trust compounds quietly over years, and it tends to outlast whatever short-term advantage opacity was ever supposed to provide in the first place, long after the transaction that created it has been forgotten by everyone except the physician still living inside it.

Educational material only. Figures are illustrative and individual results vary. Images are AI-generated illustrations and don't depict actual Verdira practices, physicians, or patients. See our Disclosures.